BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raval AN, Johnston PV, Duckers HJ, Cook TD, Traverse JH, Altman PA, Dhingra R, Hematti P, Borrello I, Anderson RD, Pepine CJ. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. Int J Cardiol 2021;326:131-8. [PMID: 33091520 DOI: 10.1016/j.ijcard.2020.10.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Yousefi-ahmadipour A, Asadi F, Pirsadeghi A, Nazeri N, Vahidi R, Abazari MF, Afgar A, Mirzaei-parsa MJ. Current Status of Stem Cell Therapy and Nanofibrous Scaffolds in Cardiovascular Tissue Engineering. Regen Eng Transl Med . [DOI: 10.1007/s40883-021-00230-1] [Reference Citation Analysis]
2 Yamada S, Jeon R, Garmany A, Behfar A, Terzic A. Screening for regenerative therapy responders in heart failure. Biomark Med 2021;15:775-83. [PMID: 34169733 DOI: 10.2217/bmm-2020-0683] [Reference Citation Analysis]
3 Vaka R, Davis DR. State-of-play for cellular therapies in cardiac repair and regeneration. Stem Cells 2021. [PMID: 34448513 DOI: 10.1002/stem.3446] [Reference Citation Analysis]